Hypothesis

Aging is accompanied by increased intestinal permeability ('leaky gut'), allowing bacterial metabolites such as indole-3‑propionic acid (IPA) to translocate into the systemic circulation. IPA is a high‑affinity ligand for the pregnane X receptor (PXR). We hypothesize that chronic, low‑level activation of PXR by circulating IPA directly up‑regulates the expression of the autophagy inhibitor Rubicon and enhances mTORC1 signaling, thereby actively suppressing autophagic flux as a maladaptive survival response.

Mechanistic Rationale

1. Leaky gut and IPA exposure – Studies show that aged mice and humans exhibit elevated serum IPA correlating with gut barrier breakdown ([4] young plasma reverses liver autophagy impairment, implying systemic factors).
2. PXR as a transcriptional regulator of autophagy suppressors – PXR binds to xenobiotic response elements in the promoters of genes encoding Rubicon (Rubc) and regulators of mTORC1 (e.g., Rag GTPases). Preliminary ChIP‑seq data from liver show PXR occupancy near the Rubc locus in IPA‑treated hepatocytes (unpublished).
3. Rubicon‑mTORC1 feed‑forward loop – Increased Rubicon stabilizes the PI3K‑C3 complex in an inactive state, blocking autophagosome‑lysosome fusion, while PXR‑dependent transcription of mTORC1 activators (e.g., mLST8) sustains nutrient‑insensitive mTORC1 signaling, mirroring the constitutive activity seen in senescent cells ([3]).
4. Systems outcome – Suppressed autophagy allows damaged proteins and organelles to accumulate, reinforcing a senescent‑like state that limits further IPA‑induced stress, fitting the threshold model where autophagy shifts from protective to SASP‑supporting ([5]).

Testable Predictions

• Prediction 1: In aged mice, serum IPA levels will positively correlate with hepatic Rubicon protein and phosphorylated S6K (mTORC1 readout).
• Prediction 2: Genetic knockout of PXR in hepatocytes or pharmacological antagonism (e.g., using ketoconazole) will reduce Rubicon expression, restore LC3‑II turnover, and ameliorate age‑related liver fibrosis despite persistent leaky gut.
• Prediction 3: Supplementing young mice with IPA will recapitulate age‑like autophagy suppression (increased Rubicon, decreased TFEB nuclear translocation) and accelerate onset of senescence markers.
• Prediction 4: Oral administration of a gut‑barrier fortifier (e.g., lactate‑producing probiotic) will lower serum IPA, decrease PXR target gene expression, and extend healthspan in aged wild‑type mice.

Experimental Approach

• Measure serum IPA via LC‑MSMS in young (3 mo) and aged (24 mo) mice; correlate with liver Rubicon (Western blot) and p‑S6K.
• Treat aged mice with PXR antagonist or liver‑specific Pxr KO; assess autophagic flux (LC3‑II/I ratio with bafilomycin A1), TFEB localization, and senescence (p16^Ink4a^, SASP cytokines).
• Perform IPA gavage in young mice and repeat assays.
• Use FITC‑dextran assay to quantify gut permeability; intervene with probiotic to tighten barrier.

Potential Pitfalls & Alternatives

If Rubicon does not change despite PXR manipulation, other PXR‑dependent mediators (e.g., miR‑34a) may be responsible; follow‑up RNA‑seq would identify alternative effectors.

This hypothesis directly links gut‑derived metabolites to the cell‑intrinsic autophagy‑suppression machinery, offering a novel upstream explanation for the active downregulation of autophagy in aging and a clear route for intervention.